Guardion Health Sciences to Sell Viactiv and Complete Dissolution Process
Friday, 31 May 2024, 17:49
Guardion Health Sciences Announces Sale of Viactiv and Dissolution Plans
Guardion Health Sciences has made a strategic decision to sell Viactiv, a key asset in its portfolio, as part of its planned dissolution process. This move is expected to reshape the company's focus and deliver value to its stakeholders.
Key Points:
- Strategic Decision: The sale of Viactiv signifies a shift in Guardion Health Sciences' business strategy.
- Dissolution Process: The company aims to optimize operations and resources through this planned dissolution.
- Value Creation: Stakeholders are anticipated to benefit from the reshaping of the company's focus and future growth opportunities.
Guardion Health Sciences is strategically positioning itself for the future by divesting Viactiv and focusing on its core objectives.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.